Keyword: PMV Pharmaceuticals
AZ research exec Johnson jumps to Goldfinch, Human Longevity undergoes C-suite earthquake, Biogen poaches Takeda exec as CIO.
PMV Pharma has been trying to tackle cancer by developing small molecules to correct the mutated p53 protein without negatively affecting normal versions of it.
The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. Here are this year's standouts.
New Jersey oncology biotech PMV Pharma has seen a healthy $74 million in funding from its Series B with help from InterWest Partners, Topspin Biotech Fund (which led this round), and its Series A lead investor OrbiMed.